History of myeloid-derived suppressor cells
Open accessThe DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Abstract
Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been identified as myeloid-derived suppressor cells (MDSCs). The study of MDSCs has provided a wealth of information regarding tumour pathobiology, has extended our understanding of neoplastic progression and has modified our approaches to immune adjuvant therapy. In this Timeline article, we discuss the history of MDSCs, their influence on tumour progression and metastasis, and the crosstalk between tumour cells, MDSCs and the host macroenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Myeloid-derived suppressor cells (MDSCs), a heterogeneous group of immune cells from the myeloid lineage, are a major component of the immunosuppressive TME [93].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [93]
The cited source says what the claim attributes to it.
In the citing paper
“The TME is immunosuppressive, thus rendering the immune system less effective in killing cancer cells.”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Self-citationMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Goycoolea, A. (1997) · Cited by 3,615
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
Research works printed but not linked: 1
- Sonnenfeld A Leukamische reaktiones bei carcinoma Zeitschrift f Klin Med 1929 111
Cited by
Items 501–600 of 1,000
Liang, Y., Lü, B., Zhao, P., & Lü, W. (2019) · Journal of Cancer · doi:10.7150/jca.29647 · Cited by 36
Das, S. K., Guo, C., Pradhan, A. K., Bhoopathi, P., Talukdar, S., Shen, X., Emdad, L., Subler, M. A., Windle, J. J., Sarkar, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10040 · Cited by 35
Huijts, C. M., Lougheed, S. M., Bodalal, Z., van Herpen, C. M., Hamberg, P., Tascilar, M., Haanen, J. B. A. G., Verheul, H. M. W., de Gruijl, T. D., & van der Vliet, H. J. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2288-8 · Cited by 35
Exosomes Promote Pre-Metastatic Niche Formation in Gastric Cancer
Gao, J., Li, S., Xu, Q., Zhang, X., Huang, M., Dai, X., & Liu, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.652378 · Cited by 36
Ai, R., Yan, T., Hao, Y., Jiang, L., Dan, H., Ji, N., Zeng, X. Y., Zhou, Y. J., & Chen, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.20312 · Cited by 37
The clinical and immune features of CD14 in colorectal cancer identified via large-scale analysis
Chen, D., & Wang, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106966 · Cited by 37
Ni, X., Wang, L., Wang, H., Yu, T., Xie, J., Li, G., Liu, Y., Zhou, H., Xu, M., Hou, M., et al. (2022) · Blood · doi:10.1182/blood.2022016029 · Cited by 35
Identification of early myeloid progenitors as immunosuppressive cells
Pu, S., Qin, B., He, H., Zhan, J., Wu, Q., Zhang, X., Yang, L., Qu, C., & Zhou, Z. (2016) · Scientific Reports · doi:10.1038/srep23115 · Cited by 38
Cho, H. R., Jeon, H., Park, C., Park, S., & Choi, S. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-34242-9 · Cited by 34
Torres, J., Dhas, N. L., Longhi, M. R., & García, M. C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.593197 · Cited by 36
Wang, Z., Jiang, R., Li, Q., Wang, H., Tao, Q., & Zhai, Z. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081768 · Cited by 34
Gu, M., He, T., Yuan, Y., Duan, S., Li, X., & Shen, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.753386 · Cited by 34
Myeloid-Derived Suppressor Cells as Key Players and Promising Therapy Targets in Prostate Cancer
Siemińska, I., & Baran, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.862416 · Cited by 36
Myeloid-derived suppressor cell: A crucial player in autoimmune diseases
Xu, D., Li, C., Xu, Y., Huang, M., Cui, D., & Xie, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1021612 · Cited by 35
Qu, F., Zhou, Y., & Wu, S. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02482-w · Cited by 38
Dong, C.-X., Zhang, W., Sun, Q., Jiang, Y.-J., Fu, Z., Zhang, Y., Du, J., Sun, Y., Tao, N., & Yao, Z. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.04.153 · Cited by 34
Lnc-C/EBPβ Modulates Differentiation of MDSCs Through Downregulating IL4i1 With C/EBPβ LIP and WDR5
Gao, Y., Shang, W., Zhang, D., Zhang, S., Zhang, X., Zhang, Y., & Yang, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01661 · Cited by 35
Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward
Okła, K. (2023) · Cells · doi:10.3390/cells12141912 · Cited by 33
Hammerich, L., Warzecha, K. T., Stefkova, M., Bartneck, M., Ohl, K., Gaßler, N., Luedde, T., Trautwein, C., Tenbrock, K., & Tacke, F. (2014) · Hepatology · doi:10.1002/hep.27571 · Cited by 35
PPARγ Contributes to Immunity Induced by Cancer Cell Vaccines That Secrete GM-CSF
Goyal, G., Wong, K. K. W., Nirschl, C. J., Souders, N. C., Neuberg, D. S., Anandasabapathy, N., & Dranoff, G. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0612 · Cited by 36
Application of Anti-Inflammatory Agents in Prostate Cancer
Hatano, K., Fujita, K., & Nonomura, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082680 · Cited by 33
Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers
Mabuchi, S., & Sasano, T. (2021) · Cells · doi:10.3390/cells10051073 · Cited by 33
Role of myeloid-derived suppressor cells in tumor recurrence
Cole, K., Al-Kadhimi, Z. S., & Talmadge, J. E. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10079-1 · Cited by 33
Self-citationYang, Z., Teng, Y., Lin, M. S., Peng, Y., Du, Y., Sun, Q., Gao, D., Yuan, Q., Zhou, Y. J., Yang, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c13143 · Cited by 33
Torroella‐Kouri, M., Rodríguez, D., & Caso, R. (2013) · Immunologic Research · doi:10.1007/s12026-013-8438-3 · Cited by 35
Dissecting the Role of Bone Marrow Stromal Cells on Bone Metastases
Buenrostro, D., Park, S. I., & Sterling, J. A. R. (2014) · BioMed Research International · doi:10.1155/2014/875305 · Cited by 33
Drafting the proteome landscape of myeloid‐derived suppressor cells
Gato, M., Blanco‐Luquin, I., Zudaire, M., de Morentin, X. M., Pérez‐Valderrama, E., Zabaleta, A., Kochan, G. T., Escors, D., Fernández‐Irigoyen, J., & Santamaría, E. (2015) · PROTEOMICS · doi:10.1002/pmic.201500229 · Cited by 34
Bartmann, C., Junker, M., Segerer, S. E., Häusler, S. F., Krockenberger, M., & Kämmerer, U. (2016) · American Journal of Reproductive Immunology · doi:10.1111/aji.12492 · Cited by 33
Okano, S., Abu-Elmagd, K. M., Kish, D. D., Keslar, K. S., Baldwin, W. M., Fairchild, R. L., Fujiki, M., Khanna, A., Osman, M., Costa, G., et al. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14718 · Cited by 35
Mechanistic insights of adipocyte metabolism in regulating breast cancer progression
Zhang, F., & Liu, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104741 · Cited by 35
Garton, A. J., Seibel, S., Lopresti-Morrow, L., Crew, L., Janson, N., Mandiyan, S., Trombetta, E. S., Pankratz, S., LaVallee, T. M., & Gedrich, R. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0676 · Cited by 32
“It is reported that mouse MDSCs do not themselves express detectable KIT protein (53), and we have confirmed by flow cytometry analysis that the M-MDSCs identified during these studies lack detectable KIT expression (data not shown), suggesting that the effect of anti-KIT treatment on M-MDSCs is likely to be indirect…”
BackgroundJiang, Y., Long, G., Huang, X., Wang, W., Cheng, B., & Pan, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06351-3 · Cited by 32
The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities
Liu, X., Kang, X., Kang, H., & Yan, H. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02170-7 · Cited by 33
Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes
Itoh, A., & Ridgway, W. M. (2017) · ImmunoTargets and Therapy · doi:10.2147/itt.s117264 · Cited by 32
Sceneay, J., Griessinger, C. M., Hoffmann, S. H. L., Wen, S., Wong, C. S. F., Krumeich, S., Kneilling, M., Pichler, B. J., & Möller, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196040 · Cited by 33
Taub, C. J., Lippman, M. E., Hudson, B. I., Blomberg, B. B., Diaz, A., Fisher, H. M., Nahin, E. R., Lechner, S. C., Kwak, T., Hwang, G. H., et al. (2019) · Cancer · doi:10.1002/cncr.31965 · Cited by 32
Chen, H., Jiang, T., Lin, F.-Y., Guan, H., Zheng, J., Liu, Q., Du, B., Huang, Y., & Lin, X. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107929 · Cited by 34
Extracellular Vesicles in Lung Cancer Metastasis and Their Clinical Applications
Saviana, M., Romano, G., Le, P., Acunzo, M., & Nana-Sinkam, P. S. (2021) · Cancers · doi:10.3390/cancers13225633 · Cited by 34
Schrijver, I. T., Karakike, E., Théroude, C., Baumgärtner, P., Harari, A., Giamarellos‐Bourboulis, E. J., Calandra, T., & Roger, T. (2022) · Intensive Care Medicine Experimental · doi:10.1186/s40635-022-00431-0 · Cited by 33
Li, P., Rozich, N., Wang, J., Wang, J., Xu, Y., Herbst, B. T., Yu, R. Y.-L., Muth, S. T., Niu, N., Li, K., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215722 · Cited by 33
Hu, L.-P., Huang, W., Wang, X., Xu, C., Qin, W., Li, D., Tian, G.-A., Li, Q., Zhou, Y.-Q., Chen, S.-Y., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.06.015 · Cited by 35
Different evasion strategies in multiple myeloma
Wang, C., Wang, W., Wang, M., Deng, J., Sun, C., Hu, Y., & Luo, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1346211 · Cited by 34
Curcumin as a regulator of Th17 cells: Unveiling the mechanisms
Ghoushi, E., Poudineh, M., Parsamanesh, N., Jamialahmadi, T., & Sahebkar, A. (2024) · Food Chemistry Molecular Sciences · doi:10.1016/j.fochms.2024.100198 · Cited by 39
Pang, X., Song, H., Zhang, Q., Tu, Z., & Niu, J. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.01.014 · Cited by 32
Expression of C/EBPβ in myeloid progenitors during sepsis promotes immunosuppression
Dai, J., Kumbhare, A., Youssef, D. A., Yao, Z. Q., McCall, C. E., & Gazzar, M. E. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.09.008 · Cited by 35
Belyaev, N. N., Abdolla, N., Perfilyeva, Y. V., Ostapchuk, Y. O., Krasnoshtanov, V. K., Kali, A., & Tleulieva, R. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2067-y · Cited by 33
Myeloid-Derived Suppressor Cells in Sepsis
Lai, D., Qin, C., & Shu, Q. (2014) · BioMed Research International · doi:10.1155/2014/598654 · Cited by 33
Najac, C., Chaumeil, M. M., Kohanbash, G., Guglielmetti, C., Gordon, J. W., Okada, H., & Ronen, S. M. (2016) · Scientific Reports · doi:10.1038/srep31397 · Cited by 31
Reyes, J. L., Lopes, F., Leung, G., Mancini, N. L., Matisz, C. E., Wang, A., Thomson, E. A., Graves, N., Gilleard, J. S., & McKay, D. M. (2016) · Infection and Immunity · doi:10.1128/iai.00681-16 · Cited by 32
Wang, Z., Zhu, F., Wang, J., Tao, Q., Xu, X., Wang, H., Xiong, S., Wang, Y., & Zhai, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01202 · Cited by 32
Sun, Y., Han, X., Shang, C., Wang, Y., Xu, B., Jiang, S., Mo, Y., Wang, D., Ke, Y., & Zeng, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-021-04487-w · Cited by 31
Roles of ubiquitination in the crosstalk between tumors and the tumor microenvironment (Review)
Zhang, X., Meng, T., Cui, S., Liu, D., Pang, Q., & Wang, P. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5374 · Cited by 32
Younos, I., Abe, F., & Talmadge, J. E. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.987141 · Cited by 32
Self-citationLim, H. X., Choi, S., Cho, D., & Kim, T. S. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.72 · Cited by 31
Immune regulation and anti-cancer activity by lipid inflammatory mediators
Khadge, S., Sharp, J. G., McGuire, T. R., Thiele, G. M., Black, P. N., Dirusso, C., Cook, L. M., Klassen, L. W., & Talmadge, J. E. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.026 · Cited by 35
Self-citationGlobal Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma
Zheng, Y., Wen, Y., Cao, H., Gu, Y., Yan, L., Wang, Y., Wang, L., Zhang, L., & Shao, F. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s282763 · Cited by 32
PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
Deng, M., Peng, L., Li, J., Liu, X., Xia, X., & Li, G. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.763561 · Cited by 30
The Hippo Signaling Pathway: The Trader of Tumor Microenvironment
Yang, D., Zhang, N., Li, M., Hong, T., Meng, W., & Ouyang, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.772134 · Cited by 33
Sepsis induces non-classic innate immune memory in granulocytes
Wang, B., Zhu, L., Jia, B., Zhao, C., Zhang, J., Li, F., Li, J., Nan, D., Zhang, C., Yu, H., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113044 · Cited by 30
Sun, Y., Kaur, K., Kanayama, K., Morinaga, K., Park, S., Hokugo, A., Kozłowska, A. K., McBride, W. H., Li, J., Jewett, A., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.735795 · Cited by 31
Ilkovitch, D., & Ferris, L. K. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5685 · Cited by 31
Vito, A., Salem, O., El-Sayes, N., MacFawn, I., Portillo, A. L., Milne, K., Harrington, D., Ashkar, A. A., Wan, Y., Workenhe, S. T., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02375-9 · Cited by 32
Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1
Dillen, A., Bui, I., Jung, M., Agioti, S., Zaravinos, A., & Bonavida, B. (2024) · Cancers · doi:10.3390/cancers16061237 · Cited by 29
Yang, L., Zhang, D., Lu, D., Shi, Y., Jia, G., Wang, S., Zhang, K., Zhao, K., & Luan, Y. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.152032 · Cited by 29
Aldrich, A. L., Heim, C. E., Shi, W., Fallet, R. W., Duan, B., & Kielian, T. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01793-6 · Cited by 29
Martínez‐Useros, J., Martin-Galan, M., & García‐Foncillas, J. (2021) · Cancers · doi:10.3390/cancers13020322 · Cited by 30
Metformin as a booster of cancer immunotherapy
Panaampon, J., Zhou, Y., & Saengboonmee, C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110528 · Cited by 31
HLA-DR Expression on Monocyte Subsets in Critically Ill Children
Boeddha, N. P., Kerklaan, D., Dunbar, A., van Puffelen, E., Nagtzaam, N. M. A., Vanhorebeek, I., den Berghe, G. V., Hazelzet, J. A., Joosten, K. F. M., Verbruggen, S. C. A. T., et al. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001990 · Cited by 31
Chemokines in breast cancer: Regulating metabolism
Gao, D. F., & Fish, E. N. (2018) · Cytokine · doi:10.1016/j.cyto.2018.02.010 · Cited by 31
Myeloid-derived suppressor cells and their role in gynecological malignancies
Mabuchi, S., Yokoi, E., Komura, N., & Kimura, T. (2018) · Tumor Biology · doi:10.1177/1010428318776485 · Cited by 29
Chae, Y. K., Oh, M. S., & Giles, F. J. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0354 · Cited by 28
Hetta, H. F., Zahran, A. M., Mansor, S. G., Abdelmalek, M. O., Mekky, M. A., & Abbas, W. A. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25428 · Cited by 29
Fan, X., Jin, J., Yan, L., Liu, L., Li, Q., & Xu, Y. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108551 · Cited by 30
Aldrich, A. L., Horn, C. M., Heim, C. E., Korshoj, L. E., & Kielian, T. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001042 · Cited by 28
Transforming growth f actor‐beta1 and m yeloid‐derived suppressor cells: A cancerous partnership
Mojsilović, S. B., Mojsilović, S. S., Bjelica, S., & Santibanez, J. F. (2021) · Developmental Dynamics · doi:10.1002/dvdy.339 · Cited by 28
Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good
Grassi, G., Notari, S., Gili, S., Bordoni, V., Casetti, R., Cimini, E., Tartaglia, E., Mariotti, D., Agrati, C., & Sacchi, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.842949 · Cited by 30
Role of myeloid-derived suppressor cells in the formation of pre-metastatic niche
Ya, G., Ren, W., Qin, R., He, J., & Zhao, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.975261 · Cited by 29
Han, C., Wu, T., Na, N., Zhao, Y., Li, W., & Zhao, Y. X. (2016) · Inflammation Research · doi:10.1007/s00011-016-0949-7 · Cited by 29
Zhao, T., Ding, X., Du, H., & Yan, C. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.04.014 · Cited by 28
RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells
Soong, R.-S., Anchoori, R. K., Yang, B. K., Yang, A. D., Tseng, S.-H., He, L., Tsai, Y.-C., Roden, R. B. S., & Hung, C. (2016) · Oncotarget · doi:10.18632/oncotarget.12095 · Cited by 29
Zhang, J., Hodges, A., Chen, S., & Pan, P. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104300 · Cited by 32
Tumor‐associated neutrophils (TANs) in human carcinoma‐draining lymph nodes: a novel TAN compartment
Lonardi, S., Missale, F., Calza, S., Bugatti, M., Vescovi, R., Bresciani, D., Uppaluri, R., Egloff, A. M., Mattavelli, D., Lombardi, D., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1252 · Cited by 28
Takizawa, S., Murao, A., Ochani, M., Aziz, M., & Wang, P. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3hi0620-416r · Cited by 29
Understanding Immune Thrombocytopenia: Looking Out of the Box
Schifferli, A., Cavalli, F., Godeau, B., Liebman, H. A., Recher, M., Imbach, P. A., & Kühne, T. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.613192 · Cited by 31
Interpreting Immunoregulation in Lung Fibrosis: A New Branch of the Immune Model
Huaux, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690375 · Cited by 31
O’Connor, M. A., Fu, W. W., Green, K. A., & Green, W. R. (2015) · Virology · doi:10.1016/j.virol.2015.07.020 · Cited by 28
Characterization of the inflammatory response during Ehrlich ascitic tumor development
Fernandes, P. D., Guerra, F. S., Sales, N. M., Giorno, T. B. S., Jancar, S., & Neves, J. S. (2014) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2014.09.001 · Cited by 32
Zhu, J., Chen, S., Wu, L., Wang, R., Zheng, S., Zhao, D., Wang, X., & Li, J. (2018) · BioMed Research International · doi:10.1155/2018/5474828 · Cited by 27
Kotzé, L. A., Young, C., Leukes, V., John, V., Fang, Z., Walzl, G., Lutz, M. B., & du Plessis, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102670 · Cited by 28
Targeting myeloid regulators by paclitaxel-loaded enzymatically degradable nanocups
Burkert, S. C., Shurin, G. V., White, D. L., He, X., Kapralov, A. A., Kagan, V. E., Shurin, M. R., & Star, A. (2018) · Nanoscale · doi:10.1039/c8nr04437f · Cited by 27
Wang, Z., & Wu, X. (2021) · Oncology Reports · doi:10.3892/or.2021.8135 · Cited by 29
Interaction Between microRNAs and Myeloid-Derived Suppressor Cells in Tumor Microenvironment
Liang, L., Xu, X., Li, J., & Yang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883683 · Cited by 26
Neobavaisoflavone inhibits antitumor immunosuppression via myeloid-derived suppressor cells
Guo, J., Shen, Y., Hu, S., Tao, R. X., Liu, J., & Yuan, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109103 · Cited by 26
Immunoregulatory functions of mature CD10+ and immature CD10– neutrophils in sepsis patients
Liu, M., Wang, G., Wang, L., Wang, Y., Bian, Y., Shi, H., & Liu, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1100756 · Cited by 26
Persistent immunosuppressive effects of dibutyl phthalate exposure in adult male mice
Pierozan, P., Källsten, L., Theodoropoulou, E., Almamoun, R., & Karlsson, O. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.162741 · Cited by 26
Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives
Maselli, F. M., Giuliani, F., Laface, C., Perrone, M., Melaccio, A., Santis, P. D., Santoro, A. N., Guarini, C., Iaia, M. L., & Fedele, P. (2023) · Current Oncology · doi:10.3390/curroncol30060432 · Cited by 28
Cappello, P., Tonoli, E., Curto, R., Giordano, D., Giovarelli, M., & Novelli, F. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1112940 · Cited by 26
Dross, S., Munson, P. V., Kim, S. E., Bratt, D., Tunggal, H. C., Gervassi, A. L., FULLER, D. H., & Horton, H. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600759 · Cited by 29
Acuff, N. V., & Linden, J. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602077 · Cited by 26
Sevmiş, M., Yöyen-Ermiş, D., Aydin, C., Bilgiç, E., Korkusuz, P., Üner, A., Hamaloğlu, E., Esendağlı, G., & Karakoç, D. (2017) · Immunological Investigations · doi:10.1080/08820139.2017.1360339 · Cited by 26
Metadata
- Authors
- Talmadge, J. E., & Gabrilovich, D. I.
- Affiliations
- University of Nebraska Medical Center (US)
- The Wistar Institute (US)
- Corresponding author
- Talmadge, James E.
- Venue
- Nature Reviews Cancer
- Published
- 2013-09-24
- Volume
- 13
- Issue
- 10
- Pages
- 739-752
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4358792
- OpenAlex
- W2122403898
- Cited by
- 1,148
- References
- 197
- Citations by year
- 2026: 29 · 2025: 57 · 2024: 80 · 2023: 74 · 2022: 105 · 2021: 132 · 2020: 110 · 2019: 95 · 2018: 101 · 2017: 90 · 2016: 129 · 2015: 93 · 2014: 43 · 2013: 7
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA084488, R01CA100062)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- myeloid-derived suppressor cells, tumor microenvironment, T cell suppression, immune evasion, tumor progression, metastasis, multipotent progenitors
- MeSH terms
- Animals, Antigens, Differentiation, Antigens, Neoplasm, Cell Differentiation, Cell Biology, Hematopoiesis, Extramedullary, Humans, Leukemoid Reaction, Medical Oncology, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Chemokines, Cell Lineage, Tumor Escape, Hematopoietic Stem Cell Mobilization, Myeloid Cells, Myeloid Progenitor Cells, Multipotent Stem Cells, Tumor Burden, History, 20th Century, History, 21st Century, Mice, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.